Literature DB >> 12204535

Telomere dysfunction provokes regional amplification and deletion in cancer genomes.

Rónán C O'Hagan1, Sandy Chang, Richard S Maser, Ramya Mohan, Steven E Artandi, Lynda Chin, Ronald A DePinho.   

Abstract

Telomere dysfunction and associated fusion-breakage in the mouse encourages epithelial carcinogenesis and a more humanized genomic profile that includes nonreciprocal translocations (NRTs). Here, array comparative genomic hybridization was used to determine the pathogenic significance of NRTs and to determine whether telomere dysfunction also drives amplifications and deletions of cancer-relevant loci. Compared to tumors arising in mice with intact telomeres, tumors with telomere dysfunction possessed higher levels of genomic instability and showed numerous amplifications and deletions in regions syntenic to human cancer hotspots. These observations suggest that telomere-based crisis provides a mechanism of chromosomal instability, including regional amplifications and deletions, that drives carcinogenesis. This model provides a platform for discovery of genes responsible for the major cancers affecting aged humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204535     DOI: 10.1016/s1535-6108(02)00094-6

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  79 in total

1.  DNA synthesis generates terminal duplications that seal end-to-end chromosome fusions.

Authors:  Mia Rochelle Lowden; Stephane Flibotte; Donald G Moerman; Shawn Ahmed
Journal:  Science       Date:  2011-04-22       Impact factor: 47.728

2.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation.

Authors:  Christina Y Soohoo; Rong Shi; Tae Ho Lee; Pengyu Huang; Kun Ping Lu; Xiao Zhen Zhou
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

Review 4.  Chromosomes and cancer cells.

Authors:  Sarah L Thompson; Duane A Compton
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

Review 5.  Understanding telomere diseases through analysis of patient-derived iPS cells.

Authors:  Luis F Z Batista; Steven E Artandi
Journal:  Curr Opin Genet Dev       Date:  2013-08-28       Impact factor: 5.578

6.  The nature of telomere fusion and a definition of the critical telomere length in human cells.

Authors:  Rebecca Capper; Bethan Britt-Compton; Maira Tankimanova; Jan Rowson; Boitelo Letsolo; Stephen Man; Michele Haughton; Duncan M Baird
Journal:  Genes Dev       Date:  2007-10-01       Impact factor: 11.361

7.  Modeling Genomic Instability and Selection Pressure in a Mouse Model of Melanoma.

Authors:  Lawrence N Kwong; Lihua Zou; Sharmeen Chagani; Chandra Sekhar Pedamallu; Mingguang Liu; Shan Jiang; Alexei Protopopov; Jianhua Zhang; Gad Getz; Lynda Chin
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

8.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

Review 9.  Pancreatic carcinogenesis.

Authors:  Jan-Bart M Koorstra; Steven R Hustinx; G Johan A Offerhaus; Anirban Maitra
Journal:  Pancreatology       Date:  2008-04-01       Impact factor: 3.996

Review 10.  Translating insights from the cancer genome into clinical practice.

Authors:  Lynda Chin; Joe W Gray
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.